International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 671-677, 1 March 2008

Assessment of External Beam Radiation Technology for Dose Escalation and Normal Tissue Protection in the Treatment of Prostate Cancer

  • David J. D'Ambrosio, M.D.

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
  • ,
  • Alan Pollack, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
  • ,
  • Eleanor E.R. Harris, M.D.

      Affiliations

    • Division of Radiation Oncology, H. Lee Moffit Cancer Center, Tampa, FL
  • ,
  • Robert A. Price Jr., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
  • ,
  • Lynn J. Verhey, Ph.D.

      Affiliations

    • Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, CA
  • ,
  • Mack Roach III, M.D.

      Affiliations

    • Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, CA
  • ,
  • D. Jeffrey Demanes, M.D.

      Affiliations

    • California Endocurietherapy Cancer Center (CET), Oakland, CA
  • ,
  • Michael L. Steinberg, M.D.

      Affiliations

    • Santa Monica Cancer Treatment Center, Santa Monica, CA
  • ,
  • Louis Potters, M.D.

      Affiliations

    • Department of Radiation Oncology, South Nassau Communities Hospital, Oceanside, NY
  • ,
  • Paul E. Wallner, D.O.

      Affiliations

    • 21st Century Oncology, Moorestown, NJ
  • ,
  • Andre Konski, M.D., M.B.A., M.A.

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • Corresponding Author InformationReprint requests to: Andre Konski, M.D., M.B.A., M.A., Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. Tel: (215) 728-2940; Fax: (215) 214-1629

Received 11 April 2007; received in revised form 14 September 2007; accepted 14 September 2007.

Prostate cancer, Dose escalation, IMRT, Biochemical failure, Normal tissue toxicity

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by departmental Varian research grant (A.P.); Departmental Siemens research grant (L.J.V.); ASTRO IMRT/3D-CRT Practicum faculty (R.A.P.); honoraria: Siemens (M.R.), ASTRO (M.R., P.E.W.), Nomos (M.L.S.), Glaxo Smith Kline (P.E.W.); Oncura and Theragenics meeting grant (L.P.).

PII: S0360-3016(07)04261-7

doi:10.1016/j.ijrobp.2007.09.034

Refers to article:

  • Technology Assessment: Vigilance Required

    W. Robert Lee
    International Journal of Radiation Oncology * Biology * Physics 1 March 2008 (Vol. 70, Issue 3, Pages 652-653)

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 671-677, 1 March 2008